Proteomics International Laboratories Ltd (ASX:PIQ), a pioneer in predictive diagnostics, is pleased to announce the appointment of James Williams to its Board as an independent nonexecutive director, effective 16 September 2024.
Proteomics International Laboratories Ltd (ASX:PIQ), a pioneer in predictive diagnostics is pleased to announce groundbreaking results showing the PromarkerD predictive test can predict renal decline in type 1 diabetes.
Proteomics International Laboratories Ltd (ASX:PIQ), a pioneer in predictive diagnostics is pleased to provide the following update on its business activities for the three months to 30 June 2024.
Proteomics International Laboratories Ltd (ASX:PIQ), a pioneer in predictive diagnostics is pleased to announce that Eurobio Scientific has been appointed to distribute its PromarkerD predictive test for diabetic kidney disease in France.
Proteomics International Laboratories Ltd (ASX:PIQ), a pioneer in predictive diagnostics is pleased to announce it has engaged the medical device sales agency, Growth Medics B.V., to assist with the identification and selection of EU alliance partners for its PromarkerD predictive test for diabetic kidney disease.
Join Ellis Martin and Money Talk Radio for a conversation with Dr. Moutih Rafei, Chief Science Officer of Defence Therapeutics (CNSX:DTC) (FRA:DTC) (OTCMKTS:DTCFF).
Proteomics International Laboratories Ltd (ASX:PIQ), a pioneer in predictive diagnostics is pleased to confirm the successful collaboration with Curtin University's Centre for Crop and Disease Management (CCDM), with researchers making an important breakthrough in understanding how dieback impacts plants.
